Precigen, Inc. (PGEN) vs Tyra Biosciences, Inc. (TYRA)

Precigen, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Precigen, Inc. and Tyra Biosciences, Inc. are of similar size ($1.5B and $1.4B). Tyra Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 60.3×. Precigen, Inc. has the higher net margin (15.6% vs 0.00%) and the higher return on invested capital (15.9% vs 0.00%). Across the 14 metrics below, Precigen, Inc. leads on 9 and Tyra Biosciences, Inc. on 5.

Valuation

Metric PGEN TYRA Biotechnology median
P/E 60.27 n/m 10.60
P/S 10.11 n/m 9.40
P/B 18.94 3.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 43.41 n/m 0.66
EV/Sales 10.51 n/m 9.02
Earnings yield 1.66% (11.38%) (32.88%)
Free cash flow yield (4.68%) (7.90%) (23.13%)

Profitability

Metric PGEN TYRA Biotechnology median
Gross margin 91.42% 0.00% 68.51%
Operating margin 21.43% 0.00% 0.00%
Net margin 15.55% 0.00% 0.00%
Free cash flow margin (47.35%) 0.00% 0.00%
Return on equity 38.84% (45.31%) (51.96%)
Return on assets 12.73% (42.15%) (46.06%)
Return on invested capital 15.93% 0.00% 0.00%

Growth

Metric PGEN TYRA Biotechnology median
Revenue growth (TTM) 2,387.61% — 6.76%
EPS growth (last fiscal year) (191.49%) (33.11%) 29.88%
Revenue growth, 5-year CAGR (21.26%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PGEN TYRA Biotechnology median
Debt to equity 1.12 0.00 0.00
Current ratio 5.58 14.91 4.97
Net debt to EBITDA 0.04 1.94 1.01

Dividend

Metric PGEN TYRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PGEN TYRA Biotechnology median
Market cap 1.51b 1.44b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack